New Hampshire Trust

Position in MRK — Merck & Co., Inc.

CIK 1961742 CONCORD, NH

Position in MRK

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$6,961,487

+$269,755 QoQ

Shares Held

54,175

-2.6% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

1.92%

of 13F equity value

Holder Rank

#888

of 3,769 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

New Hampshire Trust holds $23,591,468 across 9 Drug Manufacturers - General names. MRK ranks #2 (29.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	33,795	$8,504,172
2	MRK	Merck & Co., Inc. This page	54,175	$6,961,487
3	JNJ	Johnson & Johnson	15,285	$3,881,930
4	NVS	Novartis AG	7,170	$1,123,681
5	LLY	ELI LILLY & Co	933	$1,119,067
6	AMGN	Amgen Inc	2,237	$810,062
7	BMY	Bristol Myers Squibb Co	9,927	$571,992
8	PFE	Pfizer Inc	16,564	$398,861

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,961,487	54,175	-2.6%	Shares	Sole	2026-07-27
2026-03-31	$6,691,732	55,630	-0.3%	Shares	Sole	2026-04-20
2025-12-31	$5,871,507	55,781	-5.8%	Shares	Defined	2026-01-29
2025-09-30	$4,969,914	59,215	+10.2%	Shares	Defined	2025-10-16
2025-06-30	$4,254,374	53,744	+1.8%	Shares	Defined	2025-07-31
2025-03-31	$4,739,596	52,803	+6.9%	Shares	Defined	2025-04-08
2024-12-31	$4,911,924	49,376	+1.7%	Shares	Defined	2025-01-16
2024-09-30	$5,512,428	48,542	-0.2%	Shares	Defined	2024-10-17
2024-06-30	$6,020,145	48,628	+0.3%	Shares	Defined	2024-07-15
2024-03-31	$6,396,275	48,475	-1.9%	Shares	Defined	2024-04-09
2023-12-31	$5,388,312	49,425	-0.1%	Shares	Defined	2024-01-12
2023-09-30	$5,095,818	49,498	-0.6%	Shares	Defined	2023-10-17
2023-06-30	$5,748,729	49,820	-2.3%	Shares	Defined	2023-07-11
2023-03-31	$5,423,336	50,976	-9.7%	Shares	Sole	2023-04-18
2022-12-31	$6,261,685	56,437	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.